Endo International PLC (MEX:ENDP)
MXN 169 0 (0%) Market Cap: 42.98 Mil Enterprise Value: -13.09 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 50/100

Endo International PLC at JPMorgan Healthcare Conference Transcript

Jan 13, 2020 / 11:30PM GMT
Release Date Price: MXN85.28
Christopher Thomas Schott
JP Morgan Chase & Co, Research Division - Senior Analyst

Great. Good. 7:30, let's -- good afternoon, everybody. I'm Chris Schott from JPMorgan, and very pleased to be introducing Endo this afternoon. From Endo, we have Paul Campanelli, the company's Chairman and CEO, and it's going to be Paul's last presentation as a CEO of Endo -- so -- at the JPMorgan conference, so congrats on that, and we look forward to the presentation.

Paul V. Campanelli
Endo International plc - Chairman, President & CEO

Thank you, Chris. And just for clarification, I'm actually retiring. So definitive. No. Thank you.

Today is incredibly exciting to be here. I'm joined here by Blaise Coleman, our Executive Vice President and our Chief Financial Officer. When we break out, I'll also have our commercial leads on the brand side. We've got Pat Barry. And also on the sterile and generic side, we've got Domenic Ciarico and Laure Park is with us with respect to Corporate Affairs and Investor Relations. So with that, it's an honor and a privilege to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot